Precigen

Precigen is a U.S.-listed biopharmaceutical company focused on developing and commercializing gene and cell therapies. Its programs target immuno-oncology, autoimmune disorders, and infectious diseases, with a commercial-stage presence in advanced precision medicines.

Relationship details are part of the Pro plan.